Kálmán Tóth

14.9k total citations · 1 hit paper
185 papers, 4.8k citations indexed

About

Kálmán Tóth is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kálmán Tóth has authored 185 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cardiology and Cardiovascular Medicine, 53 papers in Surgery and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kálmán Tóth's work include Blood properties and coagulation (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Kálmán Tóth is often cited by papers focused on Blood properties and coagulation (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Kálmán Tóth collaborates with scholars based in Hungary, United States and United Kingdom. Kálmán Tóth's co-authors include Gábor Késmárky, Róbert Halmosi, Eszter Szabados, Balázs Sümegi, P. Kenyeres, Gergely Fehér, Miklós Rábai, László Czopf, Tamás Habon and I. Juricskay and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Kálmán Tóth

174 papers receiving 4.6k citations

Hit Papers

Clinical efficacy and saf... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
    2017 469 citations Kálmán Tóth et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kálmán Tóth 1.2k 1.1k 1.1k 750 614 185 4.8k
Xian Wu Cheng 1.7k 1.4× 1.2k 1.0× 773 0.7× 373 0.5× 782 1.3× 195 5.1k
Zuyi Yuan 1.7k 1.4× 1.4k 1.2× 968 0.9× 375 0.5× 548 0.9× 240 5.3k
Germano Guerra 1.4k 1.1× 554 0.5× 979 0.9× 642 0.9× 611 1.0× 180 5.0k
Giovanni G. Camici 2.7k 2.3× 1.6k 1.4× 861 0.8× 425 0.6× 1.3k 2.2× 214 7.2k
Cheng Zhang 2.6k 2.2× 1.7k 1.4× 761 0.7× 622 0.8× 626 1.0× 216 6.2k
Michael M. Hoffmann 1.1k 0.9× 552 0.5× 1.4k 1.3× 285 0.4× 555 0.9× 143 4.5k
Liberato Berrino 2.0k 1.7× 1.7k 1.5× 577 0.5× 557 0.7× 1.1k 1.8× 165 6.5k
Yimin Cui 1.0k 0.9× 539 0.5× 694 0.6× 379 0.5× 265 0.4× 266 4.5k
Jinying Zhang 1.8k 1.5× 1.4k 1.2× 1.3k 1.2× 509 0.7× 307 0.5× 210 6.5k
Guangyan Cai 2.2k 1.9× 390 0.3× 716 0.7× 615 0.8× 1.0k 1.6× 338 6.8k

Countries citing papers authored by Kálmán Tóth

Since Specialization
Citations

This map shows the geographic impact of Kálmán Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kálmán Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kálmán Tóth more than expected).

Fields of papers citing papers by Kálmán Tóth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kálmán Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kálmán Tóth. The network helps show where Kálmán Tóth may publish in the future.

Co-authorship network of co-authors of Kálmán Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Kálmán Tóth. A scholar is included among the top collaborators of Kálmán Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kálmán Tóth. Kálmán Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sándor, Barbara, Anita Pálfi, László Deres, et al.. (2025). Prevalence and Cardiopulmonary Characteristics of Post-COVID Syndrome at a Hungarian Tertiary Referral Hospital. Journal of Clinical Medicine. 14(8). 2604–2604.
2.
3.
Juhász, Kata, Katalin Fekete, Ferenc Gallyas, et al.. (2024). Cardiac effects of OPA1 protein promotion in a transgenic animal model. PLoS ONE. 19(11). e0310394–e0310394. 2 indexed citations
4.
Biró, Katalin T., D. Endrei, Katalin Koltai, et al.. (2023). Screening for Peripheral Artery Disease Using an Automated Four-Limb Blood Pressure Monitor Equipped with Toe–Brachial Index Measurement. Journal of Clinical Medicine. 12(20). 6539–6539. 1 indexed citations
5.
Biró, Katalin T., Barbara Sándor, Katalin Koltai, et al.. (2023). Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication. Biomedicines. 11(8). 2181–2181. 2 indexed citations
6.
Biró, Katalin T., D. Endrei, Katalin Koltai, et al.. (2023). Oscillometric measurement of the ankle-brachial index and the estimated carotid-femoral pulse wave velocity improves the sensitivity of an automated device in screening peripheral artery disease. Frontiers in Cardiovascular Medicine. 10. 1275856–1275856. 4 indexed citations
7.
Sándor, Barbara, et al.. (2023). Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. International Journal of Molecular Sciences. 24(5). 4405–4405. 14 indexed citations
8.
Jackson, Scott, et al.. (2023). Substance Use-Associated Mortality among Heart Donors after the COVID-19 National Emergency Increased but Did Not Affect Peri-Transplant Outcomes. Journal of Cardiovascular Development and Disease. 10(5). 222–222. 2 indexed citations
9.
10.
Deres, László, et al.. (2021). The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results. International Journal of Molecular Sciences. 22(18). 10152–10152. 77 indexed citations
11.
Deres, László, et al.. (2021). BGP‐15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats. Oxidative Medicine and Cellular Longevity. 2021(1). 1250858–1250858. 15 indexed citations
12.
Kenyeres, P., et al.. (2020). Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol. Cardiovascular Therapeutics. 2020. 1–8. 24 indexed citations
13.
Deres, László, Krisztián Erős, Barbara Sándor, et al.. (2020). Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure. Antioxidants. 9(11). 1108–1108. 40 indexed citations
14.
Fehér, Gergely, Péter Csécsei, Judit Papp, et al.. (2020). The Role of Adjuvant Vinpocetine Therapy in Aspirin-Treated Cerebrovascular Patients. 7(1). 942–945. 2 indexed citations
15.
16.
Deres, László, et al.. (2017). Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model. Oxidative Medicine and Cellular Longevity. 2017(1). 6819281–6819281. 97 indexed citations
17.
Tóth, Ambrus, Judit Papp, Miklós Rábai, et al.. (2014). The role of hemorheological factors in cardiovascular medicine. Clinical Hemorheology and Microcirculation. 56(3). 197–204. 23 indexed citations
18.
Tóth, Kálmán, et al.. (2012). OFLOXACIN LOADED, IN-SITU - GELLING, CALCIUM ALGINATE HYDROGEL IN THE LOCAL TREATMENT OF BONE AND SOFT TISSUE INFECTIONS IN ORTHOPAEDIC SURGERY. FARMACIA. 60(5). 711–720. 1 indexed citations
19.
György, Bence, Károly Módos, Éva Pállinger, et al.. (2010). Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 117(4). e39–e48. 342 indexed citations
20.
Kenyeres, P., I. Juricskay, Gábor Késmárky, et al.. (2008). Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease.. PubMed. 38(1). 51–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xian Wu Cheng Breakdown of academic impact, for papers by Zuyi Yuan Breakdown of academic impact, for papers by Germano Guerra Breakdown of academic impact, for papers by Giovanni G. Camici Breakdown of academic impact, for papers by Cheng Zhang Breakdown of academic impact, for papers by Michael M. Hoffmann Breakdown of academic impact, for papers by Liberato Berrino Breakdown of academic impact, for papers by Yimin Cui Breakdown of academic impact, for papers by Jinying Zhang Breakdown of academic impact, for papers by Guangyan Cai
Rankless by CCL
2026